Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
Milestone Scientific Strengthens Board to Support Next Phase of Growth
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript
Milestone Scientific Reports Financial Results for First Quarter 2026
Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption
Milestone Scientific Inc. Completes $2.15 Million Private Placement
Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript
Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025
Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call
Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion
Milestone Scientific (NYSE:MLSS) Trading Down 2.3% – Here’s What Happened
Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry
Milestone Scientific (NYSE:MLSS) Trading 3.1% Higher – Here’s What Happened
Milestone Scientific (NYSE:MLSS) Shares Down 1.6% – Here’s Why
Milestone Scientific Inc. (MLSS) Q3 2025 Earnings Call Transcript
Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership
Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification
Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management
Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer
Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
Milestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price Assignment
Milestone Scientific Inc. (MLSS) Q2 2024 Earnings Call Transcript
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024
Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida
Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe
Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024